 | • レポートコード：C-MOR-100154 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、臨床試験支援サービスの世界市場について調査・分析し、臨床試験支援サービスの世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
The clinical trials support services market will show rapid growth due to the demand for clinical trials in the emerging markets, high R&D spending of the pharmaceutical industry and the increasing number of CROs and prevalence of diseases.
In emerging countries, there are numerous unmet needs of clinical trials for novel drugs, due to the increasing prevalence of infectious and tropical diseases in the region. The number of individuals suffering from insulin resistance, hyperlipidemia, and obesity is increasing rapidly in these regions and, the cost of conducting clinical trials is relatively cheaper, due to fewer labor costs and low costs for handling clinical trial supplies. Thus the demand for clinical trials in emerging countries is expected to drive the clinical trials support services market’s growth over the forecast period.
The research and development (R&D) spending of pharmaceutical companies has also been steadily increasing over the past few years. This was mainly due to numerous patent expiries, and as a result of the patent expiration, there are many pharmaceutical companies that will have no other option but to develop new revolutionary molecules for survival. Therefore, the companies are spending more on R&D to accelerate the development of drugs through clinical trials, and henceforth increasing the overall market.
Scope of the Report
As per the scope of the report, clinical trial support services are the various services, which pharmaceutical companies use during the clinical trials they conduct, either for the approval of new drug molecules or for the introduction of generics and biosimilars into the market.
Key Market Trends
Phase I is anticipated to be the Growing Segment During the Forecast Period
Clinical trials support services for phase-I include services, like early-phase patient screening, sample collection management, data management, and assay redesign services, among others. The United States, Europe, and China, followed by Canada and Australia are thus found be the major hubs, where a large set of Phase-I clinical trials are being registered and conducted. Thus, it is a major market for clinical trial management services.
Despite the trend of outsourcing, the developing countries host a significantly small fraction of Phase I trials. Thus the increasing number of Investigative New Drug (IND) applications filed and the trend of outsourcing plays a major role in the drug development process.
North America Region Holds the Largest Market Share of Clinical Trials Support Services Market
North America is found to be one of the largest markets for global clinical trials support services owing to the maximum number of pharmaceutical firms based in the United States to conduct most of their business in this region. There are also increasing R&D investments and growing demand for drug development that are the main factors for the growth of the overall market.
Moreover, owing to the trend of clinical trial outsourcing, the clinical trial site management services, for managing offshore operations has witnessed rapid growth.
Competitive Landscape
Product launches, partnerships, collaborations, agreements, and market expansions were the key strategies adopted by players to grow and expand their presence in the clinical trial management system market. The major players include Accovion GmbH, Alcura Health, Charles River Laboratories, Chiltern International Limited, Covance, Inc., ICON PLC, Parexel International, Pharmaceutical Product Development LLC, Pharmnet, Quotient Bioresearch, and WuXi PharmaTech, among others.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Demand for Clinical Trials in the Emerging Markets
4.2.2 High R&D Spending of the Pharmaceutical Industry
4.2.3 Increasing Number of CROs and Prevalence of Diseases
4.3 Market Restraints
4.3.1 Lack of Adequate Regulatory Framework for Conducting Clinical Trials in some Countries
4.3.2 Stringent Regulations for Patient Enrollment
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Phase
5.1.1 Preclinical Studies
5.1.2 Phase I
5.1.3 Phase II
5.1.4 Phase III
5.1.5 Phase IV
5.2 By Service Type
5.2.1 Clinical Trial Site Management
5.2.2 Patient Recruitment Management
5.2.3 Assay Development
5.2.4 Clinical Research
5.2.5 Contract Manufacturing
5.2.6 Packaging, Storage and Distribution Services
5.2.7 Commercialization
5.2.8 Other Service Types
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Charles River Laboratories Intl Inc.
6.1.2 Eurofins Scientific SE
6.1.3 Laboratory Corp. of America Holdings
6.1.4 The Pharmaceutical Product Development LLC
6.1.5 ALcura
6.1.6 Insight Genetics
6.1.7 Parexel International
6.1.8 Icon PLC
6.1.9 IQVIA
6.1.10 WuXi AppTec
7 MARKET OPPORTUNITIES AND FUTURE TRENDS